about
Rapid development of image analysis research tools: Bridging the gap between researcher and clinician with pyOsiriX.Development of a hybrid magnetic resonance and ultrasound imaging system.T2-Weighted 4D Magnetic Resonance Imaging for Application in Magnetic Resonance-Guided Radiotherapy Treatment Planning.Phantom for assessment of fat suppression in large field-of-view diffusion-weighted magnetic resonance imaging.Modelling DW-MRI data from primary and metastatic ovarian tumours.Quantitative assessment of the hepatic pharmacokinetics of the antimicrobial sitafloxacin in humans using in vivoF magnetic resonance spectroscopyLocalized COSY and DQF-COSY 1H-MRS sequences for investigating human tibial bone marrow in vivo and initial application to patients with acute leukemia.Reference tissue quantification of DCE-MRI data without a contrast agent calibration.Competing Technology for PET/Computed Tomography: Diffusion-weighted Magnetic Resonance Imaging.Development of a temperature-controlled phantom for magnetic resonance quality assurance of diffusion, dynamic, and relaxometry measurements.METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.A generalized framework unifying image registration and respiratory motion models and incorporating image reconstruction, for partial image data or full images.Quantitative imaging biomarkers in neuro-oncology.First MRI application of an active breathing coordinator.Multicentre imaging measurements for oncology and in the brain.Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility studyDiffusion-weighted MR neurography for the assessment of brachial plexopathy in oncological practice.Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot studyDetecting microvascular changes in the mouse spleen using optical computed tomography.Inter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone DiseaseModulation of renal oxygenation and perfusion in rat kidney monitored by quantitative diffusion and blood oxygen level dependent magnetic resonance imaging on a clinical 1.5T platform.Use of the temporal median and trimmed mean mitigates effects of respiratory motion in multiple-acquisition abdominal diffusion imaging.Segmental liver hyperintensity in malignant biliary obstruction on diffusion weighted MRI: associated MRI findings and relationship with serum alanine aminotransferase levelsAssessing response of myeloma bone disease with diffusion-weighted MRI.Distortion correction of echo-planar diffusion-weighted images of uterine cervix.Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions.The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohort.Nanoparticles in rectal cancer imaging.Separation of type and grade in cervical tumours using non-mono-exponential models of diffusion-weighted MRIArterial input functions in dynamic contrast-enhanced magnetic resonance imaging: which model performs best when assessing breast cancer response?Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging.Childhood extracranial neoplasms: the role of imaging in drug development and clinical trials.Response evaluation in mesothelioma: Beyond RECIST.Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.Body Diffusion-weighted MR Imaging in Oncology: Imaging at 3 T.Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer.
P50
Q27317305-22FF8B38-6703-4713-973D-0615D1054D23Q30432154-D5F9053A-7A24-4F31-9F98-3E7D65828CF8Q30491559-F17D9542-0229-4B45-9DFB-7F7A4BEA3F76Q30795765-58AA5918-1506-4EFD-BDAB-80823EC76E55Q30885348-B445941C-2019-4BBD-9123-6598FBA47C58Q30981489-5042480A-7BC2-4388-83A5-53C08A08777EQ31004614-DC862934-8D4F-4835-9099-4A466F14E4B2Q31093366-18A022D9-D296-4CB3-94A3-14598791225AQ31093561-DDEB4407-85E8-4B5F-81EE-FE957DF88F43Q31106559-BCE282EF-FDB8-4350-8C0A-8F4167E398E2Q31108842-9214EB2C-D008-47AE-8ADC-33DF3F5781F2Q31147727-559DF740-8824-4021-A2CA-95F9BCABFBDFQ31161846-5A7EE542-4A74-4D3A-A0F1-F6D6D7D6C992Q33472027-3FC92524-A40B-4594-A86E-5DFA4A2C55DBQ33562487-98275063-B0A2-4D52-A32A-93AE527EF6DCQ34203974-13EABD15-C7FF-443B-8329-1E66441941C0Q35141828-DD8F6281-D9DC-48CE-AAED-68E339BE7E70Q35562381-F41E7D7E-08A7-40EF-931D-D8EB3E2BFA1CQ35645547-E8FE926D-B91F-4BAF-88D9-3EA45292C74AQ35929346-AC54A7BE-1E29-409D-AFC6-1F4862614D4AQ35974239-3FF693A2-78B9-4995-A84E-E8B760050B0EQ36001776-2E7C5C5E-A70A-4847-A0D1-566C446DAC9AQ36156660-02C78DA6-38AE-4DC3-82CF-2572A6F3F29FQ36305777-04434739-6386-4546-9959-9F889AE9ED7CQ36325506-F322F5BE-CA0C-43D9-80D2-9BB2991525B9Q36727138-DB1CE1BE-D693-4AFC-ABF5-43E0E9E844D9Q36893741-D847DAAB-D736-4920-90CD-B4B8FCDF4455Q36974335-EB6EEA9A-FA34-4069-8802-D0DD5ACA7106Q36994280-C0DB5659-1BD7-48A8-A6EF-546E7CCECAFDQ37233699-7FC1AAC5-34E7-4E76-A9A5-885982BC4265Q37452768-59B21C52-FDEF-45EF-A9D1-68A282377439Q37469882-BB6BCE0B-FA3B-4BE7-8E3E-FFE9A0A1004BQ37553579-FEF32368-A6F8-4697-B7CA-37704BA6322DQ37600890-1A4A0A0F-9A38-4D4D-B9BC-EF13712D0AC6Q38007857-A13AD5CC-AFE9-43E7-A5CB-40A3DFC5CA3FQ38516659-0E6FDB4D-8B63-45A5-A63A-EE8E0F2CACB4Q38600898-2043D033-633D-4467-B955-74ED1C512031Q38633265-69B116B1-97CB-482D-98B4-6CB170CFFD69Q38650513-11E25251-7860-424B-AAD3-211A070AFE13Q38710656-C965E832-98B3-4E3D-9438-B822D0E2E5F5
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
David J Collins
@ast
David J Collins
@en
David J Collins
@es
David J Collins
@nl
type
label
David J Collins
@ast
David J Collins
@en
David J Collins
@es
David J Collins
@nl
prefLabel
David J Collins
@ast
David J Collins
@en
David J Collins
@es
David J Collins
@nl
P21
P31
P496
0000-0001-8281-1496